Regencell Bioscience's extraordinary 21,000% stock surge over the past year appears disconnected from fundamentals, with the pre-commercial biotech having minimal clinical progress and expressing doubt about its ability to remain in business. In contrast, Pfizer offers a more prudent investment with its robust pipeline including promising GLP-1 candidate MET-097i, cost-cutting improvements, attractive 8.7x forward earnings valuation, and a solid 6.4% dividend yield.

Ten large-cap stocks experienced significant declines during the week of January 26-30, 2026. Unity Software fell 31.63% following CEO comments about world models amid competition from Google's Project Genie. Precious metals stocks including Hecla Mining (down 33.33%) and Coeur Mining (down 26.13%) declined after President Trump's nomination of Kevin Warsh for Fed Chair strengthened the dollar. Healthcare stocks UnitedHealth (down 17.87%) and Humana (down 26.07%) fell after analyst downgrades. Other notable losers included The Trade Desk (down 16.61%), First Majestic Silver (down 22.86%), Axon Enterprise (down 20.88%), Reddit (down 16.79%), and Regencell Bioscience (down 13.38%).

Ten large-cap stocks experienced significant declines during the week of January 12-16, 2026. Regencell Bioscience led losses with a 42.08% drop, while Trip.com fell 20.19% following a Chinese anti-monopoly investigation. Other major decliners included Atlassian (19.82%), Figma (19.41%), HubSpot (16.56%), and Intuit (14.38%), with analyst downgrades cited for several stocks.

Ten large-cap stocks surged last week driven by defense spending increases, AI infrastructure deals, and acquisition speculation. Top performers included Regencell Bioscience (89.45% gain), Revolution Medicines (51.38% on Merck acquisition talks), Kratos Defense (36.12% on military budget expansion), AeroVironment (35.86% on Army partnership), Karman Holdings (33.91% on acquisition deal), SanDisk (33.15% on pricing strategy), Bloom Energy (30.55% on credit facility), Oklo (29.04% on Meta power deal), Applied Digital (29.48% on earnings beat), and Figure Technology (29.33% on analyst upgrade).

Shareholder rights law firm Bragar Eagel & Squire is investigating Regencell Bioscience and Camping World Holdings for potential federal securities law violations. Regencell disclosed a DOJ investigation into trading of its shares in October 2025, causing an 18.56% stock decline. Camping World revealed prior period misstatements related to deferred tax assets, resulting in a 24.79% stock price drop.

Regencell Bioscience, a Hong Kong-based pharma company with no revenue, surged over 17,000% in 2025 to reach a $11 billion market cap. The dramatic rise was driven by its low public float (only ~56 million of 494 million shares publicly available), social media buzz about its Traditional Chinese Medicine treatments for ADHD and autism, algorithmic trading, and a 38-for-1 stock split. However, the company remains in R&D stage with cumulative losses of $3.58-$4.36 million annually and faces a DOJ investigation into its trading activities.

Law firm investigating potential securities law violations for Regencell and Camping World, following DOJ investigation and financial reporting discrepancies that negatively impacted stock prices.

Regencell Bioscience Holdings (RGC) experienced a massive 9,800% stock surge in 2025, but the company has zero revenue and appears to be a risky investment despite investor excitement about its focus on Traditional Chinese Medicine for neurocognitive disorders.

Law firm Bragar Eagel & Squire is investigating potential securities law violations for four companies: Regencell, Beyond Meat, Alvotech, and Camping World, following significant stock price drops and regulatory/financial issues.

Enphase Energy reported mixed Q2 results, leading to a rise in its stock price. Several other companies saw significant pre-market movements, both positive and negative, due to various news and earnings reports.

Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market. Kaleyra, Inc. (NYSE: KLR) shares jumped 38.3% to $6.64 after Tata Communications Limited announced it has entered an agreement to acquire the company. Theriva Biologics, Inc. (NYSE: TOVX) shares jumped 30.6% to $1.0808 after the company said Orphan Drug Designation was granted by the U.S. Food and Drug Administration for VCN-01 for the treatment of pancreatic cancer. Joby Aviation, Inc. (NYSE: JOBY) gained 26.4% to $8.08 after the company announced it received a permit that allows the company to begin flight testing of its first production prototype. Baosheng Media Group Holdings Limited (NASDAQ: BAOS) shares gained 22.4% to $9.12. Xponential Fitness, Inc. (NYSE: XPOF) surged 18.1% to $18.57. JX Luxventure Limited (NASDAQ: JXJT) rose 17.4% to $2.36. Motorcar Parts of America, Inc. (NASDAQ: MPAA) gained 16.3% to $8.19. Archer Aviation Inc. (NYSE: ACHR) rose 15.6% to $3.92. Stellantis reported a 10.6% stake in Archer Aviation Class A Common Stock as of June 23. IronNet, Inc. (NYSE: IRNT) gained 14.8% to $0.23. Doma Holdings Inc. (NYSE: DOMA) surged 13.8% to $0.2026. Lichen China Limited (NASDAQ: LICN) rose 13.5% to $1.51. Opendoor Technologies Inc. (NASDAQ: OPEN) jumped 13.3% to $3.8550. eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) gained 11.3% to $0.7001. Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares climbed 11.1% to $0.4776 after declining around 14% on Tuesday. Avalo Therapeutics recently announced its Phase 2 Peak trial ...

Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding. Forza X1, Inc. (NASDAQ: FRZA) shares jumped 94.3% to $2.4299 after the company tweeted Friday 'Get ready for something extraordinary! Stay tuned!' Chijet Motor Company, Inc. (NASDAQ: CJET) shares gained 73% to $6.63 after dipping around 33% on Friday. The stock is experiencing an upward trend in trading Monday, driven by post-IPO volatility subsequent to its debut listing on the NASDAQ on Friday. CIRCOR International, Inc. (NYSE: CIR) surged 50.1% to $47.54 after the company announced an agreement to be acquired by KKR for $49 per share in cash. Regencell Bioscience Holdings Limited (NASDAQ: RGC) gained 35.5% to $30.49. Timber Pharmaceuticals, Inc. (NYSE: TMBR) rose 35% to $2.0139 following a positive decision from the FDA for its TMB-001 treatment. Pasithea Therapeutics Corp. (NASDAQ: KTTA) climbed 30.8% to $0.5232. Lucy Scientific Discovery announced proposal to acquire Pasithea Therapeutics for $0.60 per share in cash and $0.25 per share in Lucy stock. Dunxin Financial Holdings Limited (NYSE: DXF) gained 29.9% to $0.2671after gaining over 15% on Friday. InnSuites Hospitality Trust (NYSE: IHT) surged 27.3% to $3.0040. National CineMedia, Inc. (NASDAQ: NCMI) gained 27% to $0.38. National CineMedia announced new long-term advertising agreement with Regal Cinemas. CXApp Inc. (NASDAQ: CXAI) rose 23.7% to $12.35. Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) surged 20% to $1.8238. Journey Medical Corporation (NASDAQ: DERM) gained 20% to $1.50. CURO Group Holdings Corp. (NYSE: CURO) rose 18.8% to $1.8297. BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) gained 17.7% to $2.0249 after the company signed a worldwide license agreement to develop an antibody for treatment of autoimmune and inflammatory diseases. Getty Images Holdings, Inc. (NYSE: GETY) climbed 15.5% to $5.50. WeWork Inc. (NYSE: WE) gained 14.7% ...